News Detail
![](pdf/sunpharmadadra040724081357.jpg)
New Delhi, 4 July 2024: Sun Pharma failed to adequately clean and maintain equipment used for drug manufacturing at its Dadra-based manufacturing plant, as per the US Food and Drug Administration (USFDA).
In a warning letter View Details
In a warning letter View Details
Source : PTI
business news
sun pharma
usfda
Related News
- Illegal Medical Store Raided, Huge Cache Of Drugs Seized In Sardarpur (07-07-2024)
- Antibiotic use annually rising about 8% in outpatients, 11% in indoor patients: Experts (07-07-2024)
- CDSCO issues guidance document on export NOC for unapproved, banned and new drugs (06-07-2024)
- First case under BNS in drug abuse was filed against an illegal drug manufacturer in Telangana (06-07-2024)
- Unusually Large Injection Ampoules Found with Quacks Raise Concerns Among Medical Experts (06-07-2024)
- Ministry has yet not decided on its plan for cervical cancer vaccination campaign: Report (06-07-2024)
- 73rd IPC inaugurated in Hyderabad, with emphasis on innovation and healthcare (06-07-2024)
- No anticipatory bail to man who held illegal blood donation camp (05-07-2024)
- YEIDA set to build flatted factories for medical devices soon (05-07-2024)
- Medanta Hospital Secures Patent for Groundbreaking Cervical Cancer Treatment Device (05-07-2024)